Health Care • Hospital/Nursing Management
$473.19 ▼ -4.89
(-1.02%)
MKT CAP: $103.51B • VOL: 1.12M
52W L $354 52W H $557
HCA // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $75.60B | $70.60B | $64.97B |
| YoY Revenue Growth % | +7.1% | +8.7% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $8.01B | $6.80B | $6.19B |
| Operating Margin % | 10.6% | 9.6% | 9.5% |
| Net Income (GAAP) | $6.78B | $5.76B | $5.24B |
| EBITDA (Normalized) | $11.96B | $10.70B | $8.52B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $12.64B | $10.51B | $9.43B |
| Capital Expenditures (CapEx) | $4.94B | $4.88B | $2.92B |
| Free Cash Flow (FCF) | $7.69B | $5.64B | $6.51B |
| FCF Margin % | 10.2% | 8.0% | 10.0% |
| Return on Invested Capital (ROIC %) | 18.3% | 15.8% | 10.4% |
| Cash & Short-Term Equivalents | $1.04B | $1.93B | — |
| Total Debt (Short + Long Term) | $41.60B | $38.33B | $18.24B |
| Total Stockholders' Equity | -$6.03B | -$2.50B | $37.42B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR HCA.